|
Volumn 22, Issue 3, 2002, Pages 218-221
|
Insulin inhalation with absorption enhancer at meal-times results in almost normal postprandial insulin profiles
|
Author keywords
Diabetes therapy; Insulin inhalation; Plasma insulin profiles
|
Indexed keywords
DOCUSATE SODIUM;
GLUCOSE;
HUMAN INSULIN;
ISOPHANE INSULIN;
ADULT;
AGED;
ARTICLE;
BLOOD SAMPLING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE DURATION;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG DISTRIBUTION;
DRUG FORMULATION;
FEMALE;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPOGLYCEMIA;
INSULIN BLOOD LEVEL;
INSULIN DEPENDENT DIABETES MELLITUS;
MALE;
OBESITY;
PARTICLE SIZE;
POSTPRANDIAL STATE;
POWDER INHALER;
PRIORITY JOURNAL;
RADIOIMMUNOASSAY;
ADMINISTRATION, INHALATION;
ADULT;
AGED;
DIABETES MELLITUS, TYPE 1;
DIOCTYL SULFOSUCCINIC ACID;
FEMALE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
MALE;
MIDDLE AGED;
POSTPRANDIAL PERIOD;
SURFACE-ACTIVE AGENTS;
|
EID: 0036250039
PISSN: 14750961
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1475-097X.2002.00421.x Document Type: Article |
Times cited : (8)
|
References (23)
|